Research Article
Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer
Table 1
Distribution of clinical characteristics of the patients.
| Characteristics | Patients |
| Age (years) | | Range | 21–84 | Smoking status | | Smoker | 61 | Nonsmoker | 114 | Grade | | I+II | 99 | III+IV | 42 | Histopathology | | Invasive duct carcinoma | 114 | Lobular | 10 | Other | 18 | Clinical stage | | I+II | 98 | III+IV | 42 | Tumor size | | Smaller than 2 cm | 66 | Larger than 2 cm | 76 | Estrogen receptor | | Positive | 115 | Negative | 24 | Progesterone receptor | | Positive | 101 | Negative | 39 | HER-2 receptor | | Positive | 30 | Negative | 112 | Triple negative status | | Positive | 11 | Negative | 130 | Lymph node status | | Positive | 85 | Negative | 51 | Distant metastasis | | Positive | 3 | Negative | 139 |
|
|
Some of the patient’s demographical data could not be found. |